We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Combined Pharmaceutical Freeze Drying Service Blends German and Chinese Expertise

By LabMedica International staff writers
Posted on 20 Aug 2012
In November 2010, GEA Pharma Systems (Hürth, Germany) acquired Beijing Sino-German Tianhe Technology (BSGT; Beijing, China) to create GEA Lyophil (Beijing), Ltd. More...
Since then, the company has quadrupled turnover and enhanced its customer service by integrating German quality and Chinese economy to provide a unique combined offering to its pharmaceutical clients.

Jinbin Tang, MD, GEA Lyophil, Ltd. (Beijing) reported that the market had changed in China since the introduction of new requirements for good manufacturing practice (GMP) production. This had increased the requirement for high quality pharmaceutical freeze drying lines, especially in combination with ALUS (automatic load and unload systems), a technology in which GEA Lyophil in Germany are a recognized world authority. “The key for us is to make sure we use the facilities and talents of the Chinese and German manufacturing centers fully,” he explained. “We have made freeze drying machines in China for many years however it is GEA Lyophil, Germany that is the true master of ALUS. By combining both technologies, we have the ability to provide our customers with complete, cost-effective GMP production lines with the quality and security of outcome that would be expected from a German manufacturer.”

Heinrich Meintrup, managing director of GEA Lyophil in Germany, concurred: “Having this combined option allows us to blend the benefits of German quality with a more cost-effective approach. We have never been willing to play the ‘low cost’ game, it just doesn’t work, but this quality/price performance model makes our offering unique.”

The key markets for GEA Lyophil in China come from the pharmaceutical companies who acknowledge that they need to use recognized, top-quality equipment to compete on their local market as well as on a world export stage. “Most of our customers are making anticancer drugs, antibiotics or expensive biological products where top quality, security of outcome, and reliable containment are essential,” said Dr. Tang. “They consider our lines to represent the image of their companies.”

This approach has allowed GEA Lyophil to expand its customer base to include the top-end customers that require leading technology and also provide the economy needed for those that do not have such crucial requirements. Although China is beginning to suffer from less rapid growth than in recent years, both Dr. Tang and Mr. Meintrup are optimistic about the outlook in China. “We expect another big jump this and next year because of the new GMP regulations,” said Dr. Tang. “Beyond that we still expect above average growth from the pharmaceutical sector.”

One product that is becoming very popular in China, according to Dr. Tang, is the GEA Lyophil range of cost-effective pharmaceutical freeze dryers called Smart LYO. The systems are based on modular units that have been made using validated technology with comprehensive manufacturing skills and techniques. This keeps the costs down without compromising quality, performance, or system architecture/flexibility; makes validation and documentation easier; and reduces delivery times.

Related Links:

GEA Pharma Systems



New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The Shield test looks for this cancerous DNA to identify signals associated with colorectal cancer (Photo courtesy of Shutterstock)

Blood Tests Show Potential for Colorectal Cancer Detection

Colorectal cancer remains the second leading cause of cancer-related deaths in the United States, yet many individuals miss screening due to fear, limited access, or the burdens of test preparation.... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.